• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

High-risk patent foramen ovale increases the risk of decompression illness in divers

byBryant LimandKiera Liblik
August 10, 2023
in Cardiology, Dermatology
Reading Time: 2 mins read
β-blockers linked to improved survival in preserved ejection fraction heart failure
Share on FacebookShare on Twitter

1. In this prospective cohort study, there was an increased incidence of physician-confirmed decompression illness (DCI) in divers with high-risk patent foramen ovale (PFO) compared to those without. 

2. The study could not evaluate the significance of low-risk PFO on the incidence of decompression illness due to the low sample size.

Evidence Rating Level: 2 (Good)

Study Rundown: Divers may experience DCI during ascents without proper decompression procedures. This occurs due to the rapid formation of nitrogen gas bubbles in the bloodstream. Observation studies have previously demonstrated that PFO is present at a higher prevalence among divers who have experienced DCI compared to those who have not. Prospective studies are still needed to elucidate a causal relationship between PFO and DCI. In this prospective cohort study, adult divers with more than 50 dives annually were enrolled after the presence of PFO was determined. Divers were then followed at three and six months and then every six months for a three-year period using self-reported questionnaires about symptoms of DCI. The presence of DCI was adjudicated by blinded physicians. PFO was detected in over two-thirds of enrolled divers. Twelve divers in the PFO group experienced self-reported and physician-adjudicated symptoms of DCI, while none in the non-PFO group did. As a limitation, a small sample size and a study population of only high-frequency divers may reduce the generalizability of the study. In summary, the results of the present study suggest that rates of decompression illness are higher in adults with high-risk PFO.

Click to read the study in AIM

In-Depth [prospective study]: In this prospective cohort study, a total of 100 adult divers with more than 50 dives annually were enrolled to evaluate the association between PFO and DCI. The presence of PFO was determined by transthoracic and transesophageal echocardiography with saline contrast. In terms of follow-up, participants were assessed for three years at six-month intervals. The primary outcome was the total incidence of DCI (defined by any DCI events), DCI symptoms that required medical intervention, any DCI symptoms within 30 minutes of resurfacing from a patient-reported diver, or unexplained death within two weeks of a dive. Sixty-eight participants were found to have PFO, with over 80% being grade three which is classified as over 20 microbubbles that appeared in the left atrium using echocardiography. Across all participants, the mean follow-up period was 28.7 months. Participants reported that a total of 33,531 expected dives occurred during the study period. Twelve participants (12 events) and no participants in the PFO (19%; 5.5 per 10,000 person-dives) and non-PFO group (0%), respectively, had self-reported DCI symptoms that were adjudicated by blinded physicians (p=0.012). Ten of the twelve participants with DCI had a high-risk PFO (8.4 per 10,000 person-dives), while two had a low-risk PFO (2.0 per 10,000 person-dives; p=0.090). In summary, the present study demonstrated that high-risk PFO may be associated with an increased risk of DCI among experienced and frequent divers.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologydecompression illnessdiversDiving & Hyperbaric Medicinediving medicineemergencypatent foramen ovale
Previous Post

#VisualAbstract: Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression

Next Post

#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Prochlorperazine for migraine may lower likelihood of ED return
Chronic Disease

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

August 7, 2026
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026
Next Post
#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control

#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control

#VisualAbstract: Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

#VisualAbstract: Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

dermatomyositis

Dupilumab For Management of Bullous Pemphigoids

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.